BIOGEN ($BIIB) posted quarterly earnings results on Thursday, October 30th. The company reported earnings of $4.81 per share, beating estimates of $3.96 by $0.85. The company also reported revenue of $2,534,700,000, beating estimates of $2,385,805,622 by $148,894,378.
You can see Quiver Quantitative's $BIIB stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BIOGEN Insider Trading Activity
BIOGEN insiders have traded $BIIB stock on the open market 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $BIIB stock by insiders over the last 6 months:
- PRIYA SINGHAL (Head of Development) has made 0 purchases and 2 sales selling 4,323 shares for an estimated $549,552.
- RACHID IZZAR (Head of Global Product Strat.) sold 2,223 shares for an estimated $300,105
- CAROLINE DORSA purchased 1,235 shares for an estimated $151,559
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
BIOGEN Hedge Fund Activity
We have seen 442 institutional investors add shares of BIOGEN stock to their portfolio, and 358 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- POINT72 ASSET MANAGEMENT, L.P. added 3,424,470 shares (+840.9%) to their portfolio in Q2 2025, for an estimated $430,079,187
- BLACKROCK, INC. removed 1,655,570 shares (-10.9%) from their portfolio in Q2 2025, for an estimated $207,923,036
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 1,265,814 shares (-47.6%) from their portfolio in Q2 2025, for an estimated $158,973,580
- AMUNDI removed 736,150 shares (-55.9%) from their portfolio in Q2 2025, for an estimated $92,453,078
- ORION PORFOLIO SOLUTIONS, LLC added 509,809 shares (+6828.4%) to their portfolio in Q2 2025, for an estimated $64,026,912
- ALYESKA INVESTMENT GROUP, L.P. added 508,773 shares (+inf%) to their portfolio in Q2 2025, for an estimated $63,896,801
- QUBE RESEARCH & TECHNOLOGIES LTD removed 483,400 shares (-39.4%) from their portfolio in Q2 2025, for an estimated $60,710,206
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BIOGEN Government Contracts
We have seen $43,476 of award payments to $BIIB over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- QALSODY BULK: $43,476
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
BIOGEN Congressional Stock Trading
Members of Congress have traded $BIIB stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $BIIB stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN purchased up to $15,000 on 05/15.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
BIOGEN Analyst Ratings
Wall Street analysts have issued reports on $BIIB in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Jefferies issued a "Buy" rating on 09/25/2025
- HC Wainwright & Co. issued a "Buy" rating on 08/01/2025
- RBC Capital issued a "Outperform" rating on 08/01/2025
- Mizuho issued a "Outperform" rating on 05/07/2025
To track analyst ratings and price targets for BIOGEN, check out Quiver Quantitative's $BIIB forecast page.
BIOGEN Price Targets
Multiple analysts have issued price targets for $BIIB recently. We have seen 9 analysts offer price targets for $BIIB in the last 6 months, with a median target of $169.0.
Here are some recent targets:
- Matthew Harrison from Morgan Stanley set a target price of $149.0 on 10/10/2025
- Andrew Tsai from Jefferies set a target price of $190.0 on 09/25/2025
- David Amsellem from Piper Sandler set a target price of $118.0 on 08/14/2025
- Brian Abrahams from RBC Capital set a target price of $219.0 on 08/01/2025
- Geoff Meacham from Citigroup set a target price of $135.0 on 08/01/2025
- Andrew Fein from HC Wainwright & Co. set a target price of $194.0 on 08/01/2025
- Laura Chico from Wedbush set a target price of $121.0 on 06/12/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
